Skip to main content
Equibles
ESTA logo

ESTA · Establishment Labs Holdings Inc. · Metrics

Track ESTA — free

Use ESTA with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research ESTA.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$63.52 +1.24 (+1.99%) At close · Oct 22
Russell 2000 member Rebalance outlook locked
Market Cap
$1.89B
Shares
29.80M
Volume · Oct 22 762.56K Avg daily vol (3M) 428.41K

ESTA metrics

90 of 122 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$63.52
Market cap
$1.89B

Price action

20 metrics
Price change (1W)
+3.5%
Price change (30D)
-9.6%
Price change (3M)
-30.3%
Price change (6M)
-2.5%
Price change (YTD)
-12.8%
Price change (1Y)
+27.4%
Trailing year
Price change (5Y)
-17.5%
52-week high
$95.65
52-week low
$47.80
Change from 52-week high
-33.6%
Change from 52-week low
+32.9%
Annualized volatility
54.2%
Annualized volatility (3M)
49.0%
Beta
1.4
RSI (14D)
48.4
Price vs SMA 50
-6.9%
Price vs SMA 200
-12.3%
Avg volume (3M)
428,406
Relative volume
1.8
Average dollar volume
$31.51M

Company

3 metrics
Sector
Healthcare
Industry
Medical Devices
Shares outstanding
29.80M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
8.3×
reciprocal yield 12.0%
EV / EBITDA
—
EV / EBIT
—
P / sales
7.6×
reciprocal yield 13.2%
P / book
85.9
reciprocal yield 1.2%
FCF yield
-2.2%
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
-2.1%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
8.4×
reciprocal yield 11.9%
EV / revenue historical average (5Y)
9.4×
reciprocal yield 10.6%
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
2026-10-29
Last earnings
2026-08-06

Profitability

9 metrics
Gross margin
70.5%
Operating margin
-7.6%
Trailing 12 months
Net margin
-15.8%
Gross profit (TTM)
$173.27M
Operating profit (TTM)
−$18.76M
Net income (TTM)
−$38.89M
Trailing 12 months
Diluted EPS (TTM)
$-1.29
FCF margin
-16.9%
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
$8.18
Gross profit per diluted share (TTM)
$5.77
Operating profit per diluted share (TTM)
$-0.62
EBITDA per diluted share (TTM)
$-0.76
Net income per diluted share (TTM)
$-1.30
Operating cash flow per diluted share (TTM)
$-1.08
Free cash flow per diluted share (TTM)
$-1.39
Capital expenditures per diluted share (TTM)
$0.31
R&D per diluted share (TTM)
$0.68
Stock compensation per diluted share (TTM)
$0.39
Book value per share
$0.80

Growth

11 metrics
Revenue growth YoY
+31.7%
Year over year
Net income growth YoY
—
Revenue (TTM)
$245.82M
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+4.2%
Year over year · more shares
Revenue CAGR (3Y)
+9.3%
Revenue CAGR (5Y)
+20.0%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
-180.0%
Return on assets
-11.1%
Debt / equity
12.1
Current ratio
3.8
EBITDA (TTM)
−$22.37M
Free cash flow (TTM)
−$41.51M
Quick ratio
2.5
Interest coverage
-0.7
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
−$190.54M
Latest balance sheet
Cash & equivalents
$71.16M
Total assets
$351.93M
Total debt
$261.70M

Cash flow & spend

7 metrics
Operating cash flow (TTM)
−$32.32M
Capital expenditures (TTM)
$9.18M
R&D (TTM)
$20.33M
SG&A (TTM)
$171.70M
Stock compensation (TTM)
$11.82M
R&D / revenue
8.3%
Stock compensation / revenue
4.8%

Ownership (13F)

9 metrics
13F filers
198
13F filer change QoQ
+19
Institutional ownership
95.8%
Conviction holders (share of 13F filers)
5.1%
Crowding (high-turnover and private-fund holders)
58.6%
Private-fund adviser ownership
53.7%
Active holders' share change QoQ
-2.5%
Holder tenure
14.0
Price vs estimated holder cost
+48.2%

Ownership (registered funds)

1 metrics
Index-fund ownership
0.4%

Short interest

3 metrics
Short interest
13.4%
Latest settlement · 12.1 days to cover
Days to cover
12.1d
Short-squeeze score
76 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 1688757 CUSIP G31249108 13F (30d) 16 filings 16 filers Visit website Investor relations